MEASURING BLOOD FLOW IN THE SKELETAL MUSCLE
MICROCIRCULATION USING LASER SPECKLE FLOWMETRY

A Senior Project
presented to
the Faculty of Biomedical and General Engineering Department
California Polytechnic State University,
San Luis Obispo

In Partial Fulfillment
of the Requirements for the Degree
Bachelor of Science in Biomedical Engineering
by
Kenneth Howard Gouin III
July 2015

PROJECT INFORMATION
TITLE:

Measuring Blood Flow in the Skeletal Muscle
Microcirculation using Laser Speckle Flowmetry

AUTHOR:

Kenneth Howard Gouin III

DATE SUBMITTED:

July 2015

ADVIOR:

Trevor Ryan Cardinal, Ph.D.

ii

ABSTRACT
Measuring Blood Flow in the Skeletal Muscle Microcirculation using Laser Speckle
Flowmetry
Kenneth Howard Gouin III
The presence of a native collateral circulation, which serves as a natural bypass
for blood flow around an occlusion, improves prognosis for patients with ischemic
diseases, such as peripheral arterial occlusive disease (PAOD). However, not all patients
have a native collateral circulation, and animal models suggest a genetic basis for this
variability. In mice, such as the BALB/c, that lack native arteriolar collaterals,
neocollateral formation from capillaries that connect two arterial trees can occur after
arterial occlusion, resulting in reperfusion of the ischemic watershed. Immature
arterialized collateral capillaries (ACCs) at 7 days post arterial occlusion do not
vasodilate in response to physiological stimuli and are therefore unable to match blood
flow with metabolic demand, but mature ACCs at 21 days exhibit normal vascular
reactivity. Therefore we wanted to determine if vasodilation of ACCs at 21 days post
arterial occlusion is capable of increasing flow throughout the ischemic arteriolar tree,
because the ACCs are small-caliber vessels feeding progressively larger arterioles. One
aspect of blood flow, vessel diameter, is measured routinely in our lab using bright field
intravital microscopy; however blood velocity is more challenging to measure in the
spinotrapezius microvasculature. In particular, we wanted to assess vasculature-wide
changes in blood flow, which cannot be accomplished using laser Doppler flowmetry due
to its small field of view or particle image velocimetry due to the curvature of the
spinotrapezius. Therefore, we adapted a laser speckle flowmetry (LSF) protocol to
measure blood velocity in the spinotrapezius microvasculature. In LSF, the scattering of
laser light incident on the muscle produces a characteristic speckle. This speckle changes
over time as erythrocytes flow through the vasculature of the muscle. If captured over the
finite exposure time of a detector, the speckle is blurred, and the degree of blurring is
related to the speed at which the erythrocytes are flowing through the vasculature. LSF
yields velocity information across the entire field of view, and multiple fields of view can
be stitched together to create a velocity map of the spinotrapezius vasculature. Using
LSF, in conjunction with bright field intravital microscopy, we measured blood velocity
and blood vessel diameter in vivo to quantify changes in blood flow. We found that
vasodilation of mature ACCs (i.e. at day-21) increases blood flow (288 ± 72%) in the
ischemic tree, which is comparable to the contralateral, control arterial tree (168 ± 76%),
while vasodilation of immature ACCs (i.e. at day-7) does not increase blood flow (17 ±
27%) in the ischemic tree. The ability of mature ACCs to increase flow in the ischemic
tree supports their potential as a therapeutic target for patients with PAOD who lack
native collateral vessels. Future work will include the use of a contrast agent to provide
more detailed vessel analysis (e.g. branch order effects), and similar analyses on mice
with relevant comorbidities such as diabetes mellitus and hypercholesterolemia to study
any potential impairment in arterialization and outward remodeling.

Keywords: collateral circulation, arteriogenesis, laser speckle flowmetry, laser speckle
contrast imaging, peripheral arterial occlusive disease, ischemia
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I. Introduction
Peripheral Arterial Occlusive Disease
Peripheral arterial occlusive
disease (PAOD) is characterized by a
buildup of atherosclerotic plaque in
the arteries that supply blood to the
peripheries of the body (Figure 1) as
well as the head and organs [1]. This
buildup of atherosclerotic plaque may
occlude the vessel and limit the
amount of blood supplied to the
downstream tissues [1]. If left

Figure 1. Atherosclerosis and Peripheral Arterial
Occlusive Disease. Atherosclerosis in the arteries of the
leg leads to ischemia (restriction of oxygen and nutrientrich blood flow) in downstream tissues [1].

untreated, PAOD can lead to pain and
numbness, impaired immunity, and eventual necrosis in the affected region [1].
Globally, 202 million people were living with PAOD in 2010, and the prevalence
of this disease is rising [2]. A number of treatment options currently exist depending
upon the stage of the disease. Initial treatment entails modification of the major risk
factors, which include smoking, hypertension, increased low-density lipoprotein levels,
and diabetes mellitus. Pharmaceutical treatment such as a daily regimen of aspirin or
another antithrombotic drug is often employed to reduce the risk of myocardial infarction
and stroke. Intermittent claudication, or pain in the affected tissue region, is often the first
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physical symptom to arise, and thus exercise therapy and pharmaceutical treatment are
coupled to increase motility and function of the affected region.
If initial treatment does not reverse the development of the disease, surgical or
percutaneous revascularization interventions are utilized. A major surgical intervention is
bypass grafting whereby part of an autologous vein or a synthetic scaffold is used to
make an artificial bypass around the occluded site [4]. A percutaneous intervention is
angioplasty and stenting. This entails inserting a catheter with a balloon structure at the
tip into the affected
artery and inflating the
balloon such that the
plaque is pushed against
the arterial wall and the
site is left unobstructed.
A stent (usually a

Figure 2. Endovascular Intervention. Angioplasty and stenting
surgical treatment [3].

cylindrical, metallic mesh structure) may ensheathe the balloon and thus may be
deployed with the balloon dilation to keep the artery patent after the balloon is removed
(Figure 2) [5]. Often, elderly patients are not good candidates for either of these
treatments, and recurring adverse events such as restenosis and thrombosis may follow
angioplasty and stenting. Thus there is a growing need for more effective, sustainable,
and universal treatments for occlusive diseases such as PAOD.
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The Collateral Circulation
The surgical interventions described above have been practiced for over 50 years
and still remain the standard for both coronary and peripheral occlusive disease
treatment. However, some patients have a native collateral network of blood vessels,
which consists of arterio-arteriolar anastomoses that can remodel to become functional
bypass routes for blood flow around a site of occlusion (Figure 3) [6]. During occlusion,
blood flow is diverted to the
collateral vessels, thus increasing
shear stress along the vascular walls
of the collateral network. The
increase in shear stress leads to
collateral growth and outward
remodeling, termed arteriogenesis
[7, 8]. Ultimately, this response can

Figure 3. Collateral Blood Vessels. Collateral vessels
can serve as natural bypass routes for blood flow around
an occlusion.

produce a natural bypass network
that can restore healthy function to the tissue downstream of the occlusion and thus
improve prognosis for patients with PAOD [7].
Animal studies suggest a genetic basis for the extent of the native collateral
circulation and show that collateral vessels form during embryonic development. Thus,
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there is a large intra- and inter-species variability in the number and function of collateral
vessels (Figure 4) [6].

A

B

Figure 4. Variability in Collateral Networks. Genetic variability accounts for the whole spectrum of
microcirculation, from many collateral vessels (A, canine coronary circulation) to no collateral vessels
(B, porcine coronary circulation). Black arrowheads highlight the locations where arterioles either form
collateral connections or terminate without forming collateral connections [9].

Animals lacking a native collateral circulation are more susceptible to ischemia, hypoxia
(insufficient oxygen supply to the tissue), and eventual tissue necrosis following an
occlusive event. In some animals that have no native collateral vessels, pre-existing
capillary anastomoses that connect the ischemic arterial tree to a non-occluded arterial
tree can become functional collateral vessels through a process known as collateral
capillary arteriogenesis (CCA) [10]. The capillaries undergo a type of arteriogenesis
known as arterialization, whereby they outwardly remodel and become invested with
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smooth muscle cells, which may originate from upstream arterioles or may differentiate
from mural pericytes [10]. Arterialization of capillaries may be initiated by a similar
mechanism as arteriogenesis in collateral arterioles (i.e. increased fluid shear stress as a
result of diverted blood flow through the capillaries), but the exact cellular mechanism is
unknown.
Function of Arterialized Collateral Capillaries
Although ACCs appear to be an appealing alternative treatment option for
patients with occlusive disease who lack a sufficient native collateral circulation,
reperfusion of an ischemic region is not sufficient to restore function and eliminate
physical symptoms. Equally important is the function and reactivity of the de novo
collateral vessels. Vessels must respond to the dynamic physiological conditions of the
downstream tissue by vasodilating and constricting in response to changes in metabolic
demand. There are two facets of vasodilation and constriction: lumen diameter change
and change in downstream blood flow. Both must occur for proper regulation of
perfusion and maintenance of the tissue homeostasis.
During a period of increased metabolic activity such as running, the skeletal
muscles involved require increased blood flow. The demand of the muscle is, at least in
some part, communicated to the blood vessels by contraction of muscle fibers that lie
underneath the capillary beds [11]. Hyperpolarization of arteriolar endothelial cells and
the release of nitric oxide (NO) initiates the acute relaxation of smooth muscle cells and
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local vasodilation in response to muscle contraction [12, 13, 14]. Local vasodilation
ascends upstream to the larger arterioles and feed arteries, the dominant regulators of
skeletal muscle resistance [13]. Since this cellular signaling is localized to the region of
metabolic demand, only the vessels feeding the contracting muscle dilate.
Mature ACCs (21 days post occlusion) exhibit normal reactivity in terms of
diameter increase in response to sodium nitroprusside (SNP), a smooth muscle celldependent vasodilator that is metabolized into NO, whereas immature ACCs (7 days post
occlusion) do not exhibit normal reactivity [13]. However, the hemodynamics is not as
straightforward as in the case with a normal microcirculation. In the majority of the
microcirculation, blood flows from the feed artery to the arteriole tree and then to the
capillary beds. Since blood flows from larger vessels down to smaller vessels, an increase
in luminal diameter in the larger vessel leads to an increase in flow in the smaller vessels,
given that the smaller vessels (capillaries) maintain a constant diameter. The ACCs,
however, connect two arteriolar trees, and thus blood flows from a large vessel tree (nonoccluded arteriole) to a small vessel and then into another large vessel tree (occluded
arteriole) (Figure 5). In this case, blood flow in the occluded arteriole will not increase
unless a sufficient number of ACCs feeds that arteriole. This is demonstrated by the
Hagan-Poiseuille equation (Equation 1), where blood flow is inversely proportional to the
radius of the vessel raised to the fourth power.

Flow ∝ ΔP =

6

8μLQ
πr4

(1)

Although an individual ACC is smaller in diameter than an arteriole, overall, the
flow contributions of many ACCs may serve the same function as one arteriole. If the
ACCs are capable of contributing an overall increase in flow during vasodilation then
they may function as de novo collateral vessels, and thus may serve as a viable
therapeutic target for patients lacking native collateral vessels.

Figure 5. Arterialized Collateral Capillaries. In-vivo dissecting microscope image of ACCs in the Balb/c
spinotrapezius connecting a cranial (A) and caudal (B) arteriolar tree to the ischemic tree.

State of the Art for Quantification of Blood Flow in Microcirculation
A method for measuring blood flow in the microcirculation is necessary to
evaluate the ability of ACCs to increase flow in the ischemic tree following vasodilation.
A number of methods exist for measuring blood flow in the microcirculation including
sidestream dark field microscopy, intravital video microscopy, laser doppler flowmetry,
and laser speckle flowmetry. The specific tissue preparation, anatomical constraints, and
desired results play a major role in determining which imaging modality to employ.
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Intravital Video Microscopy
Intravital video microscopy (IVVM) provides in vivo analysis of blood flow
throughout a given vasculature, but requires a high-resolution camera and a flat
preparation, usually achieved by using a window chamber. Recent studies utilize
fluorescent tracers to measure blood velocity and vessel diameters in order to calculate
blood flow. Fluorescent polystyrene microspheres or fluorescently marked erythrocytes
may be injected into the circulation of the subject (Figure 6) [17]. Images captured using
IVVM produce a streak line, showing the
distance that the fluorescent tracer traveled
during the exposure time of the image. Thus,
the centerline streak length of the fluorescent
tracer divided by the exposure time of the
image gives an approximation for the

Figure 6. Intravital Video Microscopy.
Fluorescently marked erythrocytes flowing
through an artery/vein pair [17].

centerline velocity, and flow may be
calculated using the vessel diameter [17].
In order for IVVM to provide accurate data, the entire streak line of the tracer
must be contained within the focal plane of the camera. This is difficult to achieve if the
preparation is not completely flat because the focal plane is restricted by the slightest
changes in depth. Although not reported with the fluorescently marked erythrocytes,
microspheres may collect along the luminal walls of the vessels and extravasate into the
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surrounding tissue. This impairs visualization of streak lines by producing significant
background fluorescence.
Sidestream Dark Field Microscopy
Sidestream dark field (SDF) imaging is a common, non-invasive technique for
measuring blood flow in the microcirculation. With this modality, concentric light
emitting diodes (LEDs) positioned
around the camera lens illuminate the
vessels of interest [14]. Erythrocytes
appear dark against the light tissue
background because the LEDs emit a
wavelength of light that is readily
absorbed by hemoglobin but not by
surrounding tissue or plasma (Figure

Figure 7. Sidestream Dark Field Imaging.
Sidestream dark field imaging requires close contact
of the lens with the tissue to illuminate and visualize
blood flow [15].

7) [14]. In many cases, this type of
imaging allows for direct measurement of blood flow. SDF imaging is simple and
portable, requiring a camera with a charge-coupled device (CCD) sensor connected to a
computer for data storage and analysis [16]. However, artificial manipulation of blood
flow in the region of interest can occur if the camera lens applies pressure to the vessel
[16]. In general, since the camera lens must be in close proximity to the tissue, there is a
substantial risk of contacting, and thus applying pressure to, the vessels. As another
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consequence, SDF imaging cannot be used to image an entire arteriolar tree, but only one
position along the tree because the lens may drag along the muscle and cause unintended
damage. Additionally, it is difficult to obtain flow measurements in vessels where there is
not a distinct contrast between the flowing erythrocytes and surrounding plasma, e.g. at
high flow rates or in large vessels.
Laser Doppler Flowmetry
Laser Doppler flowmetry (LDF) uses the Doppler shift that occurs when light is
reflected by moving objects to measure how fast blood cells are traveling [18]. LDF is a
non-invasive procedure that can be performed transdermally when measuring flow in
superficial vessels. The experimental setup for LDF is complex and expensive, involving
a narrow band emission laser, optical fibers for transmitting and receiving light, a high
frame rate camera, and analog/digital conversion of the signals to meaningful data [18].
LDF only provides flow information where the laser can directly illuminate, and thus
cannot be used to analyze a vascular tree or a whole network.
Laser Speckle Flowmetry
Given the unique and still unknown hemodynamics of the collateral circulation,
especially the arterialized collateral capillary network, the blood flow measurement
method must yield whole arteriolar tree information while still providing accurate flow
measurements. Laser speckle flowmetry (LSF) can be used to image an entire vascular
network and, in conjunction with bright field imaging for diameter measurements,
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provide flow information at any position along the network. Although similar to LDF,
LSF takes advantage of a different phenomenon produced by the illumination of flowing
erythrocytes with a laser.
A medium such as living tissue scatters light that is incident upon it. If the
medium is static (i.e. there are no moving objects within it) then the scattering of light
will be constant over time. If, however, there are moving objects such as cells within the
medium, then the scattering of light will change as the objects travel through the medium.
By capturing the resulting scatter pattern, or speckle, with a photodetector such as a
charge-coupled device (CCD), the convective and diffusive movements of objects within
the medium can be measured.
Laser speckle is produced by the random interference (both constructive and
destructive) that occurs during the scattering of light by the medium. This random
interference is caused by the unevenness of the scattering surface at the atomic level
(Figure 8).

Figure 8. Laser Speckle Flowmetry. Coherent light incident upon a surface creates a speckle pattern. (A)
The coherent light reflected off of a surface travels different path lengths to the image sensor as a result of
the unevenness of the surface [19]. (B) When the surface is a blood vessel, there are moving objects (red
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blood cells) within the vessel that cause uneven scattering [20]. (C) The differences in the path lengths
cause constructive and destructive interference of the signal received by the image sensor resulting in areas
of light and dark spots known as speckle [21].

Each element/pixel on the CCD registers a certain intensity of light that is dependent
upon the random interference of light hitting the element at that moment. The CCD
captures the change in the speckle pattern over time by collecting light over a given finite
exposure time. As a result, the movement of the scattering objects blurs the final recorded
speckle pattern [22]. That is, the pattern is fluctuating on a time scale smaller than the
exposure time, and thus the CCD can only record an averaged result of all of the
fluctuations that occurred during the exposure time [23]. However, this blurring effect is
of practical use because the faster that the patterns fluctuate, the more blurred the final
pattern will be.
Mathematically then, the blurring of the speckle pattern, and more specifically the
contrast of the speckle pattern, can be related to the velocity of the moving object that is
causing the speckle fluctuations. Assuming that the exposure time is constant, higher
velocity causes a decrease in speckle contrast, due to blurring of the speckle, and lower
velocity causes an increase in speckle contrast up to a theoretical maximum
corresponding to the static medium case, also known as a “fully developed speckle
pattern [24].” Since the measurement is with respect to a change in contrast, absolute
velocity cannot be determined from LSF, only changes in velocity.
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Laser Speckle Contrast Analysis Theory
The contrast value of each pixel is the most important piece of datum in LSF.
There are a number of ways to determine the velocity of a scattering object based on the
contrast of the images, however laser speckle contrast analysis (LASCA) is one of the
first to be developed and one of the most simple to implement. LASCA uses the spatial
variations in contrast for each image rather than the temporal variations in contrast over a
stack of images to determine relative velocities. In LASCA, the contrast is calculated by
using a 7 x 7 or 5 x 5 window of pixels around each pixel (Figure 9).

Figure 9. LASCA Computation Diagram. A sliding window of pixels is used to calculate the contrast
value of each pixel. The contrast value is assigned a color along a grayscale. The resulting contrast map
provides easy visualization of regions of high/low flow.

The contrast, C, of a given pixel at location (i,j) is given by the standard deviation of the
pixel intensities over the mean pixel intensity of the 7 x 7 window, as shown in equation
1 [25, 26].
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2

Cij2

=

σ7x7
ij

2
(I7x7
ij )

(2)

The contrast is directly related to the autocorrelation of the speckle, τ, which is a measure
of how similar the speckle is over time. Thus, if the speckle changes dramatically over
time, for example as a result of scattering objects moving quickly through the field of
view, then the autocorrelation of the speckle will be low. If the speckle does not change
over time, then the autocorrelation of the speckle will be high. Equation 2 shows that the
contrast is directly related to the autocorrelation by a factor of the exposure time, T, and
is inversely related to the speckle intensity, SI [25, 26].
1
τ

=

1
2TC2

= SI

(3)

The SI is used to create a “map” of the blood velocity throughout the entire vasculature.
Velocity maps are a simple way to compare individual vessel velocities as well as entire
network velocities.
Specific Aims
Specific Aim 1: To create a protocol to use laser speckle flowmetry to quantify
the change in flow in the feed arteriolar tree of the spinotrapezius muscle following
vasodilation.
Specific Aim 2: To test the hypothesis that arterialized collateral capillaries can
increase flow in the ischemic arterial tree at 21-days following ligation of the
spinotrapezius muscle lateral feed artery to a comparable extent as the sham-operated.
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Specific Aim 3: To test the hypothesis that arterialized collateral capillaries
cannot increase flow in the ischemic arterial tree at 7-days following ligation of the
spinotrapezius muscle lateral feed artery to a comparable extent as the sham-operated.
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II. Methods
Animal Care and Housing
Male Balb/c mice were housed in microisolator cages (no more than four mice per
cage) at the Cal Poly State University Vivarium, in temperature controlled (73 ± 5°F)
rooms on a 12 hour light and dark cycle. The Balb/c mice were provided with unlimited
food and water, and enrichment (contained nesting material, a plastic house, and a plastic
tube). The mice were cared for and utilized under a protocol approved by the Cal Poly
State University SLO Institutional Animal Care and Use Committee.
Spinotrapezius Ligation Surgery
The cranial, lateral feed artery of the spinotrapezius muscle was ligated and a
sham operation was performed on the contralateral muscle in a Balb/c mouse, as
previously described in [27] (Figure 10). Briefly, a small incision was made over the
cranial, lateral aspect of the spinotrapezius muscle. Overlying fascia and connective
tissue underneath the cranial fat pad was blunt dissected away to reveal the fat pad
underneath the muscle. This fat pad was blunt dissected away from the muscle to expose
the feed artery/vein pair. The artery was separated from the vein and two silk sutures
were passed underneath the artery. The upstream suture was tied first, and then the
downstream suture, and the artery was cut in between the two sutures. The fat pad was
moved back into place and the incision was sutured closed. The sham operation was
identical, but did not include the silk suture components.
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A

B

C

Figure 10. Spinotrapezius Feed Artery Ligation. Spinotrapezius feed artery ligation surgery: (A) general
diagram [10] (B) in vivo ligation indicated by black sutures (C) smooth muscle actin stain with red arrow
indicating ligation site and purple boxes indicating cranial and caudal regions of arterialized collateral
capillary formation [10].

Mouse Preparation
In un-operated animals, and at days 7 and 21 following ligation of the cranial,
lateral spinotrapezius feed artery, mice were induced using isoflurane gas (initially 5%
flowing at 0.8ml⋅min-1, and then maintained at 1-2% in oxygen flow at 0.8 – 1.2ml⋅min-1
for the duration of the procedure), and hair was removed from the dorsal aspect of the
mouse with trimming clippers and depilatory cream. The mouse was then transferred to
the surgical stage and a rectal thermistor probe was applied to provide feedback to a heatpad system that maintained the mouse’s core temperature at 35°C. An initial incision was
made above the lateral edge of the spinotrapezius muscle, followed by blunt dissection of
the underlying connective tissue, and further extension of the incision to reflect the skin
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and expose the spinotrapezius muscle. The remaining superficial fascia on the muscle
was removed to ensure maximum image quality.
Once exposed, a physiological salt solution (PSS) was irrigated over the
preparation for the entirety of the imaging process to emulate the natural, in vivo
environment of the muscle. PSS consisting of (in mM) 131.9 NaCl, 4.7 KCl, 1.17
MgSO4, 2 CaCl2, and 18 NaHCO3 was heated to 35°C, bubbled with a 95%N2/5%CO2
gas mixture (to deoxygenate it), and flowed over the exposed spinotrapezius muscle at
~2ml⋅min-1. The exposed spinotrapezius muscle was given 30 minutes after preparation
described above to equilibrate before laser speckle imaging.
Once the vessels equilibrated (reached a stable resting diameter) the baseline flow
measurements were made. The preparation was illuminated with an evenly distributed
laser beam from a 40mW Coherent Cube laser set to 30mW output power with an
expanding lens and mirror. An Olympus microscope with a 5X Olympus objective was
centered above the muscle capture images with a QImaging Retiga EXi camera mounted
to the microscope and connected to a computer via firewire cable. The QImaging
QCapture Pro 7 software was used for image acquisition. All laser speckle images were
captured with a 5ms exposure, a gain of 1, and as a stack of 60 continuous images. All
overhead lighting was turned off during imaging. Dual fiber optic goosenecks connected
to a halogen lamp were used for bright field images. Figure 11 shows the experimental
setup.
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A

B

Figure 11. Laser Speckle Flowmetry Experimental Setup. Diagram (A) and experimental setup (B)
showing the progression of imaging (larger image in appendix): 1. LED laser emits beam through
expanding lens. 2. Beam is reflected by mirror. 3. Reflected beam illuminates exposed spinotrapezius
muscle, which is superfused with PSS. 4. Resulting speckle pattern is collected by Olympus microscope. 5.
Raw data is collected by QImaging CCD camera. Image on right adapted from [24].

Bright field and laser speckle images were captured across the entire
spinotrapezius muscle. The brightfield images were used to ensure that the muscle was in
focus as well as to take vessel diameter measurements. Thus, at each position across the
muscle, a bright field image was captured before the laser speckle image. Once the
baseline images were captured, sodium nitroprusside (SNP) at a stock concentration of
10-3 M, was added to 60mL of PSS to achieve the desired concentration (10-7, 10-6, 10-5,
or 10-4 M). The 60mL PSS and SNP solution was irrigated over the preparation for 5
minutes. Bright field and laser speckle images were captured across the spinotrapezius
muscle in a similar manner such that the entire muscle was imaged after SNP application.
For the dosage response experiment, each consecutive dose was followed by a 30 minute
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resting period and proceeded from the lowest concentration (10-7 M) to the highest
concentration (10-4 M). This process was completed on both muscles for the unoperated
groups, and on the ligated muscle and then on the sham-operated muscle for day 7 and
day 21 groups.
Following completion of the imaging for the day 7 and day 21 groups, both
muscles were fixed in situ by irrigation with 4% paraformaldehyde for 15 minutes, and
resected. The muscles were post-fixed in 4% paraformaldehyde overnight before rinsing
and storing in phosphate-buffered saline. After resection, the mouse was euthanized by
cervical dislocation. Resected muscles were stained for α-smooth muscle actin, mounted,
and imaged using fluorescent microscopy. These images were used to guide the
following analysis of the laser speckle and bright field images to ensure that collateral
capillary arteriogenesis had occurred, and that the correct arteriolar trees were analyzed.
Image Processing and Measurements
Each laser speckle image stack was processed and reduced to one final contrast
map using ImageJ and algorithms that employed the laser speckle contrast analysis theory
previously presented (Figure 9). The first algorithm calculated the contrast for each pixel
by using a 7 x 7 window (equation 1). The second algorithm removed out-of-focus
images that were caused by the mouse's ventilation. Briefly, the mode pixel values of 5
randomly selected circular regions of background tissue were recorded for every image in
a stack of contrast images and any image with more than 2 of those values reaching the
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maximum possible pixel value (65535) was considered out-of-focus and removed from
the stack. This algorithm was tested on numerous sets of contrast images and the
resulting stacks were compared to manual removal of out-of-focus images to ensure that
the algorithm produced consistent results. The final algorithm created an array that stored
the median pixel value of each image in the contrast stack, calculated the median value of
that array, subtracted from each individual image the difference between the overall array
median and the individual image median, and then averaged all of the images in the stack
together into one final image. Thus, each 60-image sequence was reduced to one final
image from which laser speckle intensity (LSI) measurements were taken.
Velocity measurements were made by calculating the normalized speckle
intensity (NSI) using equation 4 [26]. The LSI was calculated in ImageJ by using the line
tool and recording the mean pixel intensity along the
length of a given vessel or background tissue (Figure
12). Each vessel measurement was paired with its own
adjacent background tissue measurement, and the length
of the line used to measure both regions was kept
constant so as to ensure that the mean was not biased by

Figure 12. LSI Measurement.
The ImageJ line tool was used to
calculate mean pixel intensity
(LSI) along the vessel and
background tissue.

the size of the sample set.

NSI =

21

LSIvessel
LSIbackground

−1

(4)

The line tool in ImageJ was used to measure vessel diameters in the corresponding bright
field images. An approximation for the blood flow in a given vessel was calculated using
equation 5 [26].
2
Flow ∝ NSI ∗ π rvessel

(5)

All percent changes were calculated by comparing the SNP-treated vessel measurements
to the baseline vessel measurements. Statistical analysis was performed using t-tests.
Results are presented as mean ± standard error.
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III. Results
In order to use laser speckle flowmetry (LSF) to assess arterialized collateral
capillary (ACC) function, we first determined if we could use LSF to detect different
degrees of blood flow changes by performing a sodium nitroprusside (SNP) dosage
response experiment in unoperated mice. Arterioles exhibited peak vasodilation at 10-5 M
SNP and the percent change in blood flow trended toward a similar behavior (Figure 13).

Figure 13. Laser Speckle Flowmetry (LSF) Dosage Response. (A and B) Representative bright field and
laser speckle contrast images, respectively, showing arteriolar reactivity with increasing SNP
concentrations from top (resting) to bottom (10-4 M). (C) Absolute arteriolar diameter at resting and after
application of each SNP concentration showing no reactivity at 10-7 M and maximal reactivity at 10-5 M.
(D) Percent change in arteriolar diameter after application of each SNP concentration showing consistent
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behavior with absolute diameters. (E) Percent change in normalized speckle intensity (NSI) showing little
change in blood velocity across the various concentrations. (F) Percent change in arteriolar blood flow
showing a similar trend to the diameter changes (D), but with large variability. All data represent 2
different spinotrapezius muscles with a total of 5 different arterioles measured.

After assessing the sensitivity of LSF to changes in blood flow, we investigated
the hypothesis that vasodilation of mature (i.e. day 21) ACCs increases blood flow in the
ischemic tree comparable to sham, while vasodilation of immature (i.e. day 7) ACCs does
not increase blood flow in the ischemic tree to a comparable extent. Vasodilation of
mature ACCs increases blood flow (288 ± 72%) in the ischemic tree, which is
comparable to the contralateral, control arterial tree (168 ± 76%), while vasodilation of
immature ACCs (i.e. at day-7) does not increase blood flow (17 ± 27%) in the ischemic
tree (Figure 14).
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Figure 14. Vasodilation of Day-21 Arterialized Collateral Capillaries (ACCs) Increases Blood Flow in
the Ischemic Tree. (A-D) Representative diameter measurements (top row) and laser speckle intensity
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(LSI) measurements (bottom row), using the line tool in ImageJ. Note that each vessel LSI measurement is
paired with an adjacent background LSI measurement. (E) Changes in vessel diameters throughout
ischemic arteriolar tree after application of sodium nitroprusside (SNP) show greater increases in day 21
post-ligation group (n=5) than sham-operated group (control, n=5), as well as greater increases in day 21
post-ligation group (n=5) than day 7 post-ligation group (n=3). (F) Changes in blood velocity throughout
ischemic arteriolar tree after application of SNP show no differences amongst sham-operated (control,
n=5), day 21 post-ligation (n=5), and day 7 post-ligation groups (n=3). (G) Changes in flow throughout
ischemic arteriolar tree after application of SNP show comparable percent increases in sham-operated
(control, n=5) and day 21 post-ligation groups (n=5), but an impaired increase at day 7 (n=3). * denotes p
< 0.05.
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IV. Discussion
Peripheral arterial occlusive disease (PAOD) is characterized by the build up of
atherosclerotic plaque in arteries supplying blood to the peripheries. This build up leads
to ischemia in the downstream tissues and eventually tissue necrosis in the absence of
clinical treatment. Current treatments such as bypass grafting and stenting are not suitable
for all patients and suffer from limitations such as restenosis. Interestingly, some patients
possess native collateral circulations that provide natural bypasses for blood flow around
an occlusion. The presence of native collateral circulations improves prognosis for
patients with ischemic disease [28]. In animals such as the Balb/c mice that generally
lack native collateral arterioles, collateral capillaries connecting two arteriole trees
undergo collateral capillary arteriogenesis (CCA) in response to an occlusion, eventually
becoming functional collaterals [10]. Once mature, these new arterialized collateral
capillaries (ACCs) exhibit phenotypic behavior of normal arterioles: vasodilating and
constricting in response to chemical signals and expressing alpha smooth muscle actin
[10, 13].
However, the ACCs are smaller in diameter than normal pre-existing collateral
arterioles (appendix A). Thus, although the CCA may restore perfusion to the ischemic
region, it is not known whether the vasodilation of the ACCs can cause an increase in
flow in the ischemic tree. In a physiological state, metabolic stress such as exercise would
require the dilation of arterioles to increase blood flow to downstream tissues. To
maximize the efficacy of CCA as a therapeutic target for patients with ischemic diseases,
such as peripheral arterial occlusive disease (PAOD), the newly formed collaterals would
have to regulate flow to meet the metabolic demands of downstream tissue.
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In order to assess ACC regulation of blood flow, we adapted a laser speckle
flowmetry (LSF) protocol from [26] to measure blood flow in the Balb/c spinotrapezius
microcirculation. We first established the accuracy and sensitivity of the imaging system
by performing a dosage response study in unoperated Balb/c mice. We used data from
previous dosage response studies performed in our lab to validate the LSF results. The
vessel diameters are consistent with previous dosage response studies, however the blood
velocity, which is proportional to the normalized laser speckle intensity (NSI), does not
change across the various vasodilator concentrations (Figure 13). Additionally, the NSI
data exhibit significant variability, which translates to variability in the overall blood
flow data. Although the flow trends toward similar behavior to the vessel diameter, the
variability obscures the sensitivity of LSF. The dosage response study suffered from a
low number of replicates, however additional explanations for the variability are
discussed further in the limitations.
We then used the LSF protocol to assess the effect of ACC vasodilation on blood
flow in the ischemic tree in Balb/c following spinotrapezius feed artery ligation. The
results supported the hypothesis that, during vasodilation, mature ACCs (21 days postligation) increase flow to the ischemic tree to a comparable extent as healthy arterioles,
and immature ACCs (7 days post-ligation) exhibit an impaired ability to increase flow
(Figure 14). These results are in agreement with previous studies showing that mature
ACCs are reactive in terms of diameter increases to physiological vasodilators such as
sodium nitroprusside (SNP) and muscle contraction, and that immature ACCs exhibit
impaired reactivity [13, 29]. The study presented here supports the role of ACCs as a
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possible therapeutic option for patients with PAOD who lack a sufficient native collateral
circulation.
Limitations and Future Work
LSF suffers from a number of limitations including uniform illumination of the
muscle and resolution of the speckle and bright field images. The spinotrapezius muscle
is located next to the spine of the mouse and thus has a natural pronounced curvature.
This makes it difficult to uniformly illuminate the muscle with an expanded laser beam
because each portion of the muscle lies at a different angle in relation to the beam. As a
result, certain portions of the muscle are more uniformly illuminated than others,
producing some images that have higher background intensities than others. Normalizing
each vessel intensity to the adjacent background intensity reduces this bias, but the data
may suffer from non-uniformity.
The ventilation of the mouse also introduces inconsistency in the speckle images.
During image acquisition, the mouse may breathe 3 or 4 times, and thus a number of the
images in the stack are out of focus because the muscle is elevated out of the focal plane
of the microscope at the peak of the ventilation cycle. Previously, the observer manually
removed the out-of-focus images before averaging the image stack. This is somewhat
subjective because an out-of-focus speckle image is not as easily identified as an out-offocus bright field image. Using ImageJ, we created a macro to automatically sort out the
undesired images based on a pixel intensity analysis in order to further standardize the
image processing and remove any subjectivity.
The sorting macro proceeded as follows: the mode pixel value of 5 randomly
selected circular regions of background tissue were recorded for every image in a stack of
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contrast images, and any image with more than 2 of those values reaching the maximum
possible pixel value (65535 for a 16-bit depth image) was considered out-of-focus and
removed from the stack. The threshold pixel value was motivated by the observation that
out-of-focus images were consistently brighter than in-focus images. We validated the
accuracy of the algorithm by testing it on numerous sets of contrast images and
comparing the results to manual removal of out-of-focus images.
Laser Speckle Resolution: Methods of Analysis
The resolution of laser speckle images is partly dependent upon the method of
analysis (i.e. the domain from which the contrast of each pixel is calculated). Spatial laser
speckle contrast analysis (sLASCA) uses a spatial domain to determine the contrast of a
particular pixel, while temporal LASCA (tLASCA) uses a temporal domain [20]. The
method used in this study is a form of sLASCA (using a 7x7 spatial window) that
includes stack normalization, effectively averaging across a temporal domain to reduce a
stack of images into one image. sLASCA returns poor spatial resolution while tLASCA
returns poor temporal resolution since each method sacrifices data in the spatial or
temporal domain, respectively [20]. Temporal resolution is not important in this study
because we are only interested in measuring relative blood flow at two distinct time
points (resting and dilated).
Some of the spatial resolution losses inherent in sLASCA are overcome by using
larger stacks of images for each field of view because there is less chance for data to be
lost during the final stack normalization. Automation of image analysis (e.g. by
automating out-of-focus image removal) allows for acquisition of larger stacks of images
at each position along the muscle because manual inspection of 60 images per stack is
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cumbersome and inefficient. Nevertheless, tLASCA is better suited for this study because
it provides better inherent spatial resolution. Spatio-temporal LASCA (stLASCA) may
provide even better resolution because it uses both spatial and temporal domains, but
sample results of these methods do not justify the longer computation time required to
complete stLASCA versus tLASCA (Figure 15).

Figure 15. Laser Speckle Analysis Methods. Different laser speckle analysis methods result in differing
spatial and temporal resolutions. (A) sLASCA calculates the contrast from the neighboring pixels in a
spatial window around the pixel of interest. (B) tLASCA calculates the contrast from the same pixel across
a number of images in a stack. (C) stLASCA calculates the contrast using a cube of pixels that extends in
the spatial and temporal domains. (A-C) were adapted from [30]. (D-F) Corresponding results from the
three methods of analysis using the same field of view, a 3x3 spatial window, and a 15 image temporal
window show a marked difference in vessel visibility. These images are contrast maps, and thus are the
inverse of the images shown in the results section. The three methods were implemented using Visual C++,
and the code is included in the appendices.
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Background Scattering
One unresolved issue that is particularly apparent in the dosage response study is
the increase in background speckle intensity concomitant with increases in vessel speckle
intensity. SNP concentrations of 10-5 M and 10-4 M exhibit the highest magnitude of
background speckle intensity (Figure 13). This rise in background signal is likely due to
the effects of vasodilation since the imaging system is not modified once the dosage
response experiment is started (i.e. the laser, camera, and mouse position do not change
over the various dosages) and the rise is consistent amongst all replicates. It is possible
that the high background signal is a result of increased capillary perfusion that cannot be
resolved by the imaging system. In the case of cranial laser speckle imaging, one of the
most common applications of LASCA, 95% of the speckle signal originates from the top
700μm of the tissue, with only 10% of parenchymal signal originating in the top 50μm
[31]. Given that the spinotrapezius is only 50-200μm thick (depending upon the location
along the muscle), it is also possible that vessels in the muscle underlying the
spinotrapezius also contribute to the background signal [27]. Regardless of the origin of
the signal, it is clear from the dosage response study that the background signal reaches a
magnitude comparable to that of the vessel, and thus normalization to the background
results in underestimation of the blood flow velocity at high SNP concentrations. Given
that there is not yet consensus on how parenchymal regions should be processed
differently from surface vessel regions, different normalization strategies should be
utilized to more accurately estimate blood flow velocity [31].
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Bright Field Resolution
The contrast analysis method affects the accuracy of blood velocity
measurements, but the accuracy of the vessel diameter measurements is equally important
for calculating blood flow. In this study, bright field imaging is used to assess vessel
diameters, but this imaging modality suffers from the inability to resolve vessels as small
as the terminal arterioles or ACCs because there is not sufficient contrast between the
vessels and the background tissue. As a result, there were not enough replicates for each
ordered vessel to provide a branch-order analysis of the flow data. Injection of a contrast
agent such as a fluorescently labeled dextran into the mouse circulation provides better
contrast, allowing for visualization of vessels at the terminal arteriole and capillary levels
(Figure 16). The accuracy of vessel diameter measurements is dependent upon accurate
discernment of the vessel walls. Thus, better contrast not only allows for visualization of
smaller vessels, but, in general, provides more accurate diameter measurements.

Figure 16. Fluorescent Contrast Agent for Vessel Visualization. Fluorescein isothiocyanate (FITC)dextran injection provides better contrast for visualization of blood vessels in vivo (all images are 5X
magnification). (A, C) Representative bright field images. (B, D) Representative fluorescent images of
same fields of view in (A) and (C). (E) Terminal arterioles leading into capillary bed. (F) Photo montage of
spinotrapezius vasculature using FITC-dextran as a contrast agent.
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We completed initial testing of contrast agents for better vessel diameter
measurements during the course of this study. FITC-dextran was used because it is
relatively inexpensive and it provides capillary-level visualization in the spinotrapezius.
Future work in this area will include the use of a jugular vein catheter to provide multiple
injections of FITC-dextran throughout the duration of imaging. This is motivated by the
observation that the FITC-dextran photobleaches during the 6-8 hour-long imaging
procedure.
Immediate future work will integrate FITC-dextran and improved laser speckle
image analysis to complete the analysis of regional and branch order effects on blood
flow. Preliminary speckle intensity data organized based on region (cranial versus caudal)
and branch order are presented in appendices C and D, respectively, however there are
not sufficient diameter measurements to calculate flow data for these categories.
Regional Hemodynamics
The imaging processes may not be the only factor in assessing blood flow because
the region of interest may also affect the data. In the Balb/c spinotrapezius, ACCs form
between the ischemic arteriole tree and the healthy arteriole trees surrounding it [10].
Most proximally to the ischemic tree ACCs form connections with one cranial tree and
one caudal tree. Alpha smooth muscle actin stains of the muscle show that the ACCs
connecting to the cranial tree are qualitatively larger than the ACCs connecting to the
caudal tree, although perhaps not as numerous (appendix C). Although not specifically
addressed in the study, representative isolectin/α-SMA images of the Balb/c
spinotrapezius 3 days post-ligation from [32] also show a higher density of collateral
capillaries in the cranial region than in the caudal region. Given that the ACCs outwardly
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remodel in response to increased shear stress, it is possible that the larger diameters of the
cranial ACCs at 21 days post-ligation indicate that this region of collateral capillaries
receives more of the redirected flow immediately after occlusion [10]. The greater
redirection of flow in the cranial region may lead to more evident rarefaction of the
cranial ACCs, a process noted in [10] to occur at 14, 21, and 42 days post-ligation,
between days 3 and 21, thus leading to larger diameters.
With the existence and function of ACCs in healthy mice established, the next
step will be to study similar processes in mice with relevant comorbidities to
atherosclerosis such as diabetes mellitus (DM) and hypercholesterolemia. These
pathological states negatively affect collateral remodeling in a number of ways, which
may translate to similar negative effects in collateral capillary arterialization and
subsequent outward remodeling involved in CCA. Heightened inflammatory states in
both DM and hypercholesterolemia may impair the recruitment of inflammatory cells
such as monocytes/macrophages to the site of remodeling. In addition, both DM and
hypercholesterolemia have negative effects on the bone marrow microenvironment, thus
causing impairments in stem cells that potentially play a role in arteriogenesis [7].
Vascular endothelial growth factor (VEGF)-resistance is associated with
hypercholesterolemia, and VEGF is a key player in arteriogenesis [33, 34]. Many
cardiovascular pathologies are associated with the inability of small arteries to remodel
over time, and thus the ability of ACCs to remodel is crucial to their therapeutic potential
in arterial occlusive diseases [35].
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Appendix A

A

B

Figure 17. Sizes of Pre-existing Collaterals and Arterialized Collateral Capillaries. Brightfield images
(5X magnification) showing the relative size of (A) pre-existing collaterals and (B) arterialized collateral
capillaries in Balb/c spinotrapezius.
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Appendix B

Figure 18. Laser Speckle Flowmetry Experimental Setup (Enlarged)Laser speckle flowmetry
experimental setup (larger version of figure 10).
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Appendix C

Figure 19. Cranial and caudal arterialized collateral capillaries. Arterialized collateral capillaries in the
cranial (upper bracket) and caudal (lower bracket) regions.

41

Figure 20. Percent Changes in Normalized Speckle Intensity by Region. Percent changes in NSI show
comparable increases in response to SNP in the cranial (n=4) and caudal (n=9) regions of the ischemic tree
21 days post-ligation.
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Appendix D

Figure 21. Percent Changes in Normalized Speckle Intensity by Branch Order. Percent changes in NSI
amongst different ordered vessels throughout the ischemic tree show comparable increases in response to
SNP at each order. Order I: control (n=4), day 7 (n=2), day 21 (n=5); Order 2: control (n=11), day 7 (n=3),
day 21 (n=8); Order 3: day 7 (n=2), day 21 (5); ACCs: day 7 (n=2), day 21 (n=3).
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Figure 22. Percent Changes in Blood Flow by Branch Order. Characterization of changes in blood flow
by first-order (control, n=3; day 7, n=2; day 21, n=3) and second-order vessels (control, n=4; day 7, n=6;
day 21, n=5).
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Appendix E
// Spatial LASCA: 3x3 spatial window
//Using OpenCV libraries
int _tmain(int argc, _TCHAR* argv[])
{
for (int l = 1; l <= 55; l++){
string String = static_cast<ostringstream*>(&(ostringstream() << l))->str();
string str = "14-1-000" + String;
Mat img = imread(path + "\\" + str + ".tif", -1);
img.convertTo(img, CV_32F);
float *ptrimg = (float *)(img.data);
std::vector<float> temporalRow;
float *outputimg = (float*)malloc(img.rows*img.cols*sizeof(float));
for (int i = 1; i < (img.rows - 1); i++) {
for (int j = 1; j < (img.cols - 1); j++) {
for (int m = (i - 1); m <= (i + 1); m++) {
for (int n = (j - 1); n <= (j + 1); n++) {
int roiIndex = m*img.cols + n;
temporalRow.push_back(ptrimg[roiIndex]);
}
}
cv::Scalar_<float> temporalMean = mean(temporalRow);
pow(temporalRow, 2, temporalRow);
cv::Scalar_<float> temporalMeanSqr = mean(temporalRow);
outputimg[i*img.cols + j] = (float)((temporalMeanSqr[0] - (temporalMean[0] *
temporalMean[0])) / temporalMean[0]);
vector<float>().swap(temporalRow);
}
}
cout << outputimg[50 * img.cols + 50] << endl;
Mat contrastimg(img.rows, img.cols, CV_32F, outputimg);
img.release();
cout << contrastimg.at<float>(50, 50) << endl;
contrastimg.convertTo(contrastimg, CV_16U);
imwrite(outputpath + "\\" + String + ".tiff", contrastimg);
free(outputimg);
contrastimg.release();
}
}
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// Temporal LASCA: 15 image temporal window
//Using OpenCV libraries
int _tmain(int argc, _TCHAR* argv[])
{
std::vector<float> temporalRow;
float *outputimg = (float*)malloc(img1.rows*img1.cols*sizeof(float));
for (int i = 1; i < (img1.rows - 1); i++) {
for (int j = 1; j < (img1.cols - 1); j++) {
int roiIndex = i*img1.cols + j;
temporalRow.push_back(ptrimg1[roiIndex]);
temporalRow.push_back(ptrimg2[roiIndex]);
temporalRow.push_back(ptrimg3[roiIndex]);
temporalRow.push_back(ptrimg4[roiIndex]);
temporalRow.push_back(ptrimg5[roiIndex]);
temporalRow.push_back(ptrimg6[roiIndex]);
temporalRow.push_back(ptrimg7[roiIndex]);
temporalRow.push_back(ptrimg8[roiIndex]);
temporalRow.push_back(ptrimg9[roiIndex]);
temporalRow.push_back(ptrimg10[roiIndex]);
temporalRow.push_back(ptrimg11[roiIndex]);
temporalRow.push_back(ptrimg12[roiIndex]);
temporalRow.push_back(ptrimg13[roiIndex]);
temporalRow.push_back(ptrimg14[roiIndex]);
temporalRow.push_back(ptrimg15[roiIndex]);
cv::Scalar_<float> temporalMean = mean(temporalRow);
pow(temporalRow, 2, temporalRow);
cv::Scalar_<float> temporalMeanSqr = mean(temporalRow);
outputimg[i*img1.cols + j] = (float)((temporalMeanSqr[0] - (temporalMean[0] *
temporalMean[0])) / temporalMean[0]);
vector<float>().swap(temporalRow);
}
}
cout << outputimg[50 * img1.cols + 50] << endl;
Mat contrastimg(img1.rows, img1.cols, CV_32F, outputimg);
cout << contrastimg.at<float>(50, 50) << endl;
contrastimg.convertTo(contrastimg, CV_16U);
imwrite(outputpath + "\\" + "tLASCA 15 result" + ".tiff", contrastimg);
}
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//Spatio-temporal LASCA: 3x3 spatial window and 15 image temporal window
//Using OpenCV libraries
int _tmain(int argc, _TCHAR* argv[])
{
std::vector<float> temporalRow;
float *outputimg = (float*)malloc(img1.rows*img1.cols*sizeof(float));
for (int i = 1; i < (img1.rows - 1); i++) {
for (int j = 1; j < (img1.cols - 1); j++) {
for (int m = (i - 1); m <= (i + 1); m++) {
for (int n = (j - 1); n <= (j + 1); n++) {
int roiIndex = m*img1.cols + n;
temporalRow.push_back(ptrimg1[roiIndex]);
temporalRow.push_back(ptrimg2[roiIndex]);
temporalRow.push_back(ptrimg3[roiIndex]);
temporalRow.push_back(ptrimg4[roiIndex]);
temporalRow.push_back(ptrimg5[roiIndex]);
temporalRow.push_back(ptrimg6[roiIndex]);
temporalRow.push_back(ptrimg7[roiIndex]);
temporalRow.push_back(ptrimg8[roiIndex]);
temporalRow.push_back(ptrimg9[roiIndex]);
temporalRow.push_back(ptrimg10[roiIndex]);
temporalRow.push_back(ptrimg11[roiIndex]);
temporalRow.push_back(ptrimg12[roiIndex]);
temporalRow.push_back(ptrimg13[roiIndex]);
temporalRow.push_back(ptrimg14[roiIndex]);
temporalRow.push_back(ptrimg15[roiIndex]);
}
}
cv::Scalar_<float> temporalMean = mean(temporalRow);
pow(temporalRow, 2, temporalRow);
cv::Scalar_<float> temporalMeanSqr = mean(temporalRow);
outputimg[i*img1.cols + j] = (float)((temporalMeanSqr[0] - (temporalMean[0] *
temporalMean[0])) / temporalMean[0]);
vector<float>().swap(temporalRow);
}
}
Mat contrastimg(img1.rows, img1.cols, CV_32F, outputimg);
contrastimg.convertTo(contrastimg, CV_16U);
imwrite(outputpath + "\\" + "stLASCA 3x3x15 result" + ".tiff", contrastimg);
contrastimg.release();
}
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Appendix F

Figure 23. Day 21 Montage 1. Day 21 laser speckle montage; resting on right, dilated on left.
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Figure 24. Day 21 Montage 2. Day 21 laser speckle montage; resting on right, dilated on left.

49

Figure 25. Day 21 Montage 3. Day 21 bright field (left) and laser speckle (right) montages; resting on top,
dilated on bottom.
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Figure 26. Day 21 Montage 4. Day 21 bright field (left), laser speckle (middle), and α-smooth muscle
actin (right) montages; resting on top, dilated on bottom.
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Figure 27. Day 21 Montage 5. Day 21 bright field (left), laser speckle (middle), and α-smooth muscle
actin (right) montages; resting on top, dilated on bottom.
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Appendix G

Figure 28. Day 7 Montage 1. Day 7 bright field (left), laser speckle (middle), and α-smooth muscle actin
(right) montages; resting on top, dilated on bottom.
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Figure 29. Day 7 Montage 2. Day 7 bright field (left), laser speckle (middle), and α-smooth muscle actin
(right) montages; resting on top, dilated on bottom.
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Figure 30. Day 7 Montage 3. Day 7 α-smooth muscle actin (left), bright field (middle), and laser speckle
(right) montages; resting on top, dilated on bottom.
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